Goldman R C, Doran C C, Capobianco J O
Anti-Infective Research Division, Pharmaceutical Discovery, Abbott Laboratories, Illinois 60064.
J Bacteriol. 1988 May;170(5):2185-91. doi: 10.1128/jb.170.5.2185-2191.1988.
Antibacterial agents which specifically inhibit CTP:CMP-3-deoxy-D-manno-octulosonate cytidylyltransferase activity were used to block the incorporation of 3-deoxy-D-manno-octulosonate (KDO) into lipopolysaccharide. Lipopolysaccharide synthesis ceased, molecules similar in structure to lipid A accumulated, and bacterial growth ceased following addition of such agents to cultures of Salmonella typhimurium and Escherichia coli. Although four major species of lipid A accumulated in S. typhimurium, their kinetics of accumulation were different. The least polar of the major species was IVA [O-(2-amino-2-deoxy-beta-D-glucopyranosyl)-(1----6)-2-amino-2-deoxy-a lph a- D-glucose, acylated at positions 2, 3, 2', and 3' with beta-hydroxymyristoyl groups and bearing phosphates at positions 1 and 4'], a molecule previously isolated from bacteria containing a kdsA mutation (C. R. H. Raetz, S. Purcell, M. V. Meyer, N. Qureshi, and K. Takayama, J. Biol. Chem. 260:16080-16088, 1985). Species IVA accumulated first and to the greatest extent following addition of the inhibitor, with other more polar derivatives appearing only after IVA attained half its maximal level. In contrast, only two major species of precursor accumulated in E. coli following addition of the inhibitor. One of these species was identical to IVA from S. typhimurium on the basis of chemical composition, fast atom bombardment mass spectroscopy, and comigration on Silica Gel H, and it also accumulated prior to a more polar species of related structure. We conclude that the addition of KDO to precursor species IVA is the major pathway of lipid A-KDO formation in both S. typhimurium LT2 and E. coli and that accumulation of the more polar species lacking KDO only occurs in response to accumulation of species IVA following inhibition of the normal pathway.
使用特异性抑制CTP:CMP - 3 - 脱氧 - D - 甘露糖辛酮酸胞苷转移酶活性的抗菌剂来阻断3 - 脱氧 - D - 甘露糖辛酮酸(KDO)掺入脂多糖。脂多糖合成停止,结构与脂质A相似的分子积累,并且在将此类试剂添加到鼠伤寒沙门氏菌和大肠杆菌培养物后细菌生长停止。尽管在鼠伤寒沙门氏菌中积累了四种主要的脂质A种类,但它们的积累动力学不同。主要种类中极性最小的是IVA [O - (2 - 氨基 - 2 - 脱氧 - β - D - 吡喃葡萄糖基) - (1→6) - 2 - 氨基 - 2 - 脱氧 - α - D - 葡萄糖,在2、3、2'和3'位被β - 羟基肉豆蔻酰基酰化,并在1和4'位带有磷酸基团],该分子先前从含有kdsA突变的细菌中分离得到(C.R.H.雷茨、S.珀塞尔、M.V.迈耶、N.库雷希和K.高山,《生物化学杂志》260:16080 - 16088,1985)。添加抑制剂后,IVA种类首先积累且积累程度最大,其他极性更大的衍生物仅在IVA达到其最大水平的一半后才出现。相比之下,添加抑制剂后大肠杆菌中仅积累了两种主要的前体种类。其中一种在化学成分、快原子轰击质谱以及在硅胶H上的共迁移方面与鼠伤寒沙门氏菌的IVA相同,并且它也在相关结构的极性更大的种类之前积累。我们得出结论,向IVA前体种类添加KDO是鼠伤寒沙门氏菌LT2和大肠杆菌中脂质A - KDO形成的主要途径,并且缺乏KDO的极性更大的种类的积累仅在正常途径被抑制后响应IVA种类的积累而发生。